new glp-1 drugs Retatrutide for weight loss: Study shows 30% body weight loss The GLP-1 Revolution: From Diabetes

It is not licensed for general prescribing

NEW FORMULATION Wegovy is now available as a once-daily oral pill FDA-approved oral GLP-1 Easy, once-daily pill ~14% weight loss at 1 year (similar to injectable) No injections or refrigeration needed Prescription & ongoing care through Healthspan 1 Based on the 64-week OASIS 4 Phase 3 clinical trial of 307 adults with obesity or overweight

N Engl J Med (2021) 384(11):989

Poor blood sugar control can worsen inflammation and metabolic health, potentially worsening sleep apnea symptoms

By reviewing fine print, testing support responsiveness, and comparing game libraries, you can identify a platform that feels intuitive on any device

2021;182 doi: 10.1016/j.nlm.2021.107463